EngageSmart Named to Energage’s 2023 Top Workplaces USA
BOSTON–(BUSINESS WIRE)–EngageSmart, Inc. (NYSE: ESMT), a leading provider of vertically tailored customer engagement software and…
BOSTON–(BUSINESS WIRE)–EngageSmart, Inc. (NYSE: ESMT), a leading provider of vertically tailored customer engagement software and…
BOSTON–(BUSINESS WIRE)–EngageSmart, Inc. (NYSE: ESMT), a leading provider of vertically tailored customer engagement software and…
WALTHAM, Mass. and BOULDER, Colo., Feb. 01, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
WALTHAM, Mass. and BOULDER, Colo., Feb. 01, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
Kigali city, as seen from the north Kigali city, as seen from the north The…
SUNNYVALE, Calif.–(BUSINESS WIRE)–Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today reported preliminary…
Emplifi’s Q4 2022 Social Media Benchmark analysis reveals social media trends; channel growth, engagement data;…
STAMFORD, Conn.–(BUSINESS WIRE)–#GartnerDA–Gartner, Inc. (NYSE: IT): What: Gartner Data & Analytics Summit 2023 When: March…
TYSONS, Va.–(BUSINESS WIRE)–Red Cell Partners (Red Cell), an incubation firm building technology-focused companies that are…
New survey from Intuit reveals Gen Z finds politics and sex easier to talk about…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
Workato was recognized for its Customer Experience with 4.9/5 ratings in Gartner Peer Insights and…
PROVO, Utah & SEATTLE–(BUSINESS WIRE)–Qualtrics (Nasdaq: XM), the leader and creator of the experience management…
Sandoz is seeking approval of high concentration formulation (HCF) adalimumab for use in all indications…
Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for…
Approximately 60% of patients aged 12 years and older treated with Dupixent 300 mg weekly…
TOKYO and CAMBRIDGE, Mass., Jan. 29, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo,…
Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022 DUBLIN, Ireland…
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
– R&D focus is on lead oncology candidate SENTI-202 for the treatment of AML and…